BUSINESS● LOW22h ago · Oct 16, 2026, 6:31 PM
Alkermes reinstated Buy at Truist on narcolepsy opportunity
Seeking Alpha Tech · global
Alkermes' stock rating was reinstated to "Buy" by Truist, based on opportunities related to narcolepsy. This indicates a positive outlook from analysts on the company's financial prospects and drug development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS10m agoSemiconductor market to remain solid ‘at least through next year,’ South Korea finance minister saysCNBCBUSINESS13m agoTG SAFE suspends FSSAI licences of four Hyderabad eateries over food safety violationsThe Hindu